Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:GEF
NYSE:GEFPackaging

Greif (GEF) Valuation Check After Strong Q1 Net Income Jump Despite Softer Sales

Greif (GEF) has drawn fresh attention after reporting first quarter earnings, with sales of US$994.8 million compared to US$1,016.7 million a year earlier and net income of US$174.6 million versus US$22 million. See our latest analysis for Greif. The earnings release appears to have been the main driver behind recent moves, with the share price now at US$71.70 and a 90 day share price return of 26.48% suggesting momentum has picked up. The 1 year total shareholder return of 22.55% and 5 year...
NYSE:AGCO
NYSE:AGCOMachinery

Assessing AGCO (AGCO) Valuation After Earnings Beat And Dividend Confirmation

AGCO (AGCO) is back in focus after reporting third quarter 2025 results that topped forecasts on both EPS and revenue, while also adopting new management compensation plans and keeping its regular dividend intact. See our latest analysis for AGCO. The latest 1 month share price return of 8.34% and 3 month gain of 9.53% put AGCO at US$114.67, with a 1 year total shareholder return of 15.10% contrasting with a weaker 3 year total shareholder return of a 6.22% decline. This suggests recent...
TSX:EDV
TSX:EDVMetals and Mining

Endeavour Mining (TSX:EDV) Is Down 8.0% After Record Dividend And Buyback Payouts - Has The Bull Case Changed?

Endeavour Mining reported past 2025 results showing gold production of 1,209 koz, higher all-in sustaining costs, record free cash flow, sharply reduced net debt and a record FY-2025 dividend of US$350.0 million, alongside completing a US$45.0 million share buyback program. The company also issued 2026 production and cost guidance broadly aligned with 2025 levels and secured an environmental permit for its Assafou project, outlining plans for first gold production there in the second half of...
NYSE:ABR
NYSE:ABRMortgage REITs

A Look At Arbor Realty Trust’s Valuation As Zacks Rank And Earnings Outlook Turn Negative

Arbor Realty Trust (ABR) has moved into the spotlight after becoming one of the most searched stocks, as investors react to expectations for lower earnings and revenue alongside a Zacks Rank #5 (Strong Sell). See our latest analysis for Arbor Realty Trust. The latest news around earnings expectations and dividend tax treatment comes against a weak trading backdrop, with a 90 day share price return of 21.53% and a 1 year total shareholder return decline of 37.44% pointing to fading...
NYSE:AB
NYSE:ABCapital Markets

A Look At AllianceBernstein (AB) Valuation After Fixed Income Shift And NAV Lending Expansion

AllianceBernstein Holding (AB) is back in focus after its fixed income chief outlined a contrarian tilt toward shorter and intermediate bonds, paired with a rally to 52 week highs and a refreshed NAV lending platform. See our latest analysis for AllianceBernstein Holding. The recent contrarian fixed income stance and NAV lending reboot have arrived alongside building momentum, with a 30 day share price return of 8.39% and a 1 year total shareholder return of 18.06% pointing to improving...
NasdaqGS:BUSE
NasdaqGS:BUSEBanks

Assessing First Busey (BUSE) Valuation After Strong Earnings And Leadership Change

Why First Busey (BUSE) Is Back on Investors’ Radar First Busey (BUSE) has attracted fresh attention after releasing fourth quarter and full year 2025 results, a leadership change, and an update on its long running share repurchase program. See our latest analysis for First Busey. The earnings release, leadership change and share repurchase update have come alongside a 12.27% 90 day share price return and a 39.40% five year total shareholder return, suggesting momentum has been building...
NYSE:LPX
NYSE:LPXForestry

Will Louisiana-Pacific’s New Independent Chair Shift LPX’s Balance Between Oversight And Execution?

Louisiana-Pacific Corporation has announced that, effective February 19, 2026, long-time director F. Nicholas Grasberger III will become independent Chairperson as current Chair and CEO W. Bradley Southern retires from the Board, while President and CEO-elect Jason P. Ringblom joins as a Class III director and two other directors plan to retire in May 2026. This leadership reshaping, pairing an independent Chair with an internal successor as CEO, signals a clearer separation of oversight and...
CPSE:HLUN B
CPSE:HLUN BPharmaceuticals

Do Real-World Vyepti Outcomes Reframe Lundbeck’s Migraine Strategy and Moat Narrative (CPSE:HLUN B)?

H. Lundbeck A/S recently presented six-month real-world data from its 12-month INFUSE study at the 2026 Headache Cooperative of the Pacific Conference in Ojai, California, highlighting outcomes for adults with migraine treated with Vyepti (eptinezumab) after prior preventive anti-CGRP failures. The data showed meaningful improvements in multiple patient-reported outcomes, including an average 6.3 additional "good days" per month, reinforcing the clinical relevance of switching to intravenous...
NYSE:NKE
NYSE:NKELuxury

Is Nike (NKE) Still Pricing In Too Much Growth After Prolonged Share Price Weakness

If you are wondering whether NIKE's current share price offers genuine value or just looks cheap on the surface, this article is designed to walk you through the key numbers in a clear and practical way. NIKE shares last closed at US$62.18, with returns of 4.3% decline over 7 days, 1.7% decline over 30 days, 1.7% decline year to date, 16.9% decline over 1 year, 47.8% decline over 3 years and 53.4% decline over 5 years. This raises questions about how the market is currently viewing its...
ENXTAM:PHARM
ENXTAM:PHARMBiotechs

Why Pharming Group (ENXTAM:PHARM) Is Down 16.3% After FDA Rejects Joenja Pediatric Expansion Plan

In early February 2026, Pharming Group reported that the U.S. FDA issued a Complete Response Letter for its supplemental New Drug Application seeking to extend Joenja’s use to children aged 4 to 11 years with APDS, requesting more pediatric pharmacokinetic data and clarification on a batch-testing analytical method. An important angle for investors is that Joenja’s existing U.S. approval for patients aged 12 and older remains intact, while younger pediatric access now hinges on resolving...
NasdaqGS:KRYS
NasdaqGS:KRYSBiotechs

Assessing Krystal Biotech (KRYS) Valuation After Analyst Optimism On Vyjuvek Expansion And Ophthalmic Pipeline

Analyst optimism and product pipeline in focus Krystal Biotech (KRYS) is back in the spotlight after several major research houses highlighted its potential to evolve into a multi product company, pointing to ophthalmic candidates KB803 and KB801 and the planned geographic expansion of Vyjuvek. See our latest analysis for Krystal Biotech. Those upbeat analyst views have landed alongside strong recent momentum, with Krystal Biotech’s share price at $282.27 and a 30 day share price return of...
NasdaqCM:RKLB
NasdaqCM:RKLBAerospace & Defense

Is It Too Late To Consider Rocket Lab (RKLB) After A 161% One Year Surge?

If you are wondering whether Rocket Lab shares still offer value after a strong run, it helps to step back and consider what the current price might already be taking into account. The stock has seen a 161.3% return over the past year and a very large return over three years. However, over the last 7 days and 30 days it has shown declines of 7.9% and 2.4%, respectively. Recent attention has centered on Rocket Lab's role as a listed space company and ongoing interest in space-related...
NasdaqGS:PENG
NasdaqGS:PENGSemiconductor

Penguin Solutions’ AI-Focused Leadership Shift Might Change The Case For Investing In Penguin Solutions (PENG)

Penguin Solutions has announced that long-time leader Mark Adams has retired as President, Chief Executive Officer and Director, with technology veteran Kash Shaikh stepping in as President, CEO, principal executive officer and Board member effective February 2, 2026, while Adams remains an advisor for nine months to support the transition. Shaikh’s three-decade career across enterprise software, SaaS, AI infrastructure and cybersecurity, most recently as CEO of Securonix and Virtana,...
NasdaqGS:LI
NasdaqGS:LIAuto

How Prolonged Delivery Declines And New Bets At Li Auto (LI) Have Changed Its Investment Story

Li Auto Inc. reported that it delivered 27,668 vehicles in January 2026, bringing its cumulative deliveries to 1,567,883 as the company rolled out an OTA 8.2 software update and continued expanding its nationwide retail and supercharging network in China. The latest data highlight ongoing sales pressure, with January marking the eighth consecutive month of year-on-year delivery declines even as Li Auto restructures R&D and pushes into pure-electric models and humanoid robotics. Next, we...
TSX:BMO
TSX:BMOBanks

A Look At Bank Of Montreal (TSX:BMO) Valuation After TD Securities Buy Upgrade

TD Securities recently upgraded Bank of Montreal (TSX:BMO) to Buy from Hold, pointing to a more favorable return on equity outlook compared with peers, which has drawn fresh attention to the bank’s shares. See our latest analysis for Bank of Montreal. BMO’s share price has been firming up, with a 1-day share price return of 2.15% at CA$189.35 and a 90-day share price return of 9.63%. Its 1-year total shareholder return of 38.78% and 5-year total shareholder return of 140.02% point to momentum...
NasdaqGS:FSUN
NasdaqGS:FSUNBanks

FirstSun Capital Bancorp (FSUN) Is Up 7.3% After Strong 2025 Earnings And Board Refresh - Has The Bull Case Changed?

FirstSun Capital Bancorp recently reported full-year 2025 results showing net interest income rising to US$317.39 million and net income increasing to US$97.94 million, alongside higher earnings per share, while also recording fourth-quarter net charge-offs of US$5.02 million. At the same time, the board is set for change as long-serving director Diane L. Merdian plans to step down and investor Peter E. Murphy, founder and CEO of Wentworth Capital Management, joins as a Class III director...
NasdaqGS:OLMA
NasdaqGS:OLMABiotechs

The Bull Case For Olema Pharmaceuticals (OLMA) Could Change Following CFO Exit Amid Palazestrant Phase 3 Focus

In late January 2026, Olema Pharmaceuticals announced the departure of Chief Operating and Financial Officer Shane Kovacs, with CEO Dr. Sean P. Bohen stepping in as interim Principal Financial Officer while the company launches an immediate search for a new CFO and retains Kovacs as a consultant through August 1, 2026. At the same time, analysts underscored the importance of Olema’s lead breast cancer candidate palazestrant and its upcoming Phase 3 program, framing leadership changes against...
TSE:7203
TSE:7203Auto

Assessing Toyota Motor (TSE:7203) Valuation After A Sustained Share Price Run

Why Toyota Motor stock is on investors’ radar today Toyota Motor (TSE:7203) is drawing attention after recent share price moves, with the stock last closing at ¥3,610 as investors reassess its size, earnings profile, and longer term return record. See our latest analysis for Toyota Motor. The recent 1-day share price return of 2.12% and 7-day share price return of 4.37% sit alongside a 30-day share price return of 7.57% and a 90-day share price return of 18.75%. The 1-year total shareholder...
NYSE:AAT
NYSE:AATREITs

A Fresh Look At American Assets Trust (AAT) Valuation After Recent Share Price Moves

American Assets Trust (AAT) is on some investors’ radar after recent share price moves, with the stock last closing at $18.03 as they reassess this real estate investment trust’s long term return profile. See our latest analysis for American Assets Trust. Recent trading has been a bit choppy, with a small 7 day share price return of 1.18% set against a 90 day share price return decline of 5.01% and a 1 year total shareholder return decline of 20.11%. This suggests that sentiment has softened...
TSE:6586
TSE:6586Machinery

Makita (TSE:6586) Is Up 17.1% After Boosting Guidance and Announcing ¥40B Share Buyback – What's Changed

In late January 2026, Makita Corporation announced a share repurchase program of up to 10,000,000 shares for ¥40,000 million, alongside raising its full‑year guidance for revenue, profit and earnings per share for the year ending March 31, 2026. The company linked its brighter outlook to stable sales despite a challenging demand backdrop and to foreign exchange movements it expects to be more favorable than previously assumed. We’ll now examine how Makita’s upgraded earnings guidance and new...